Dr. Wahid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1906 Belleview Ave SE
Roanoke, VA 24014Phone+1 540-981-7000Fax+1 540-853-0931
Education & Training
Windsor University School of MedicineClass of 2014
Certifications & Licensure
VA State Medical License 2018 - 2026
NC State Medical License 2014 - 2024
Clinical Trials
- Discharge Readmission Analysis and Management in Sepsis (DReAMS-2) Start of enrollment: 2023 Oct 26
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19.Lana Wahid, Joshua D Froess, Thomas L Ortel, Ryan Zarychanski, Jeffrey S Berger
Arteriosclerosis, Thrombosis, and Vascular Biology. 2025-01-01 - Combination Therapy Is Not Associated with Decreased Mortality in Infectious Endocarditis: A Systematic Review and Meta-Analysis.Parisa Farahani, Felicia Ruffin, Mohammad Taherahmadi, Maren Webster, Rachel E Korn
Microorganisms. 2024-11-02 - 1 citationsEffect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open...Mikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, Jeffrey S Berger, Harmony R Reynolds
The Lancet. Diabetes & Endocrinology. 2024-10-01
Press Mentions
Therapeutic-Dose Heparin Lowers Risk for VTE, Death in Hospitalized Patients with COVID-19October 28th, 2021- HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU PatientsOctober 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
